Expected outcomes: Appetite reduction, 25% waist circumference and weight loss, early visceral fat reduction, improved post-meal glucose responses Expected outcomes: 510% total body weight loss, increased insulin sensitivity, improved energy levels, lowered blood pressure Expected outcomes: Stable lean mass, reduced visceral fat, better metabolic flexibility, readiness to stop medication This programme looks beyond the bathroom scales
Akkermansia 500 PRO May Fit When: A focused single-strain product is preferred The primary goal is Akkermansia replenishment Gut-barrier ecology is a clinical priority A multi-strain metabolic formula is unnecessary A clinician wants a higher-dose Akkermansia option Important Limitations Akkermansia is not a proven standalone weight-loss intervention
Formulation Status: Easy-to-swallow oral capsules free from harsh heavy chemical preservatives, artificial binders, or heavy fillers
However, clinical evidence specifically for autoimmune applications remains limited
Melanotan II is a synthetic peptide that mimics the effects of the naturally occurring alpha-melanocyte-stimulating hormone (-MSH)
April 15, 2024
